01/17/2026
Big Pharma sees cannabis as a disruptive force that is cutting into profits from opioids, antidepressants, and sleep aids.
Pharmaceutical companies are actively lobbying against ma*****na legalization efforts.
Synthetic cannabis provides a profitable workaroundโFDA-approved, patented, and controlled.
Natural cannabis canโt be patented, making it less attractive to pharma but more appealing to patients.
Despite opposition, public support and policy reforms continue to push cannabis into the mainstream.